Company / Inventory
Arcadia Biosciences, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$1.2M
FY2025
5-year range
$904.0K / $4.4M
FY2021-FY2025
Trend
+34.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory returned to growth in FY2025 after 3 years of decline, reaching $1M.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -20.5%.
Declined from $2M to $1M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -22.2%
- 5-Year CAGR
- -20.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -20.5%, indicating a declining trend.
- In FY2025, inventory increased 34.1% year-over-year.
- Peak inventory was recorded in FY2021.
- Lowest inventory in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2M | +34.1% |
| FY2024 | $904.0K | -53.8% |
| FY2023 | $2.0M | -23.8% |
| FY2022 | $2.6M | -42.0% |
| FY2021 | $4.4M | +16.3% |
| FY2020 | $3.8M | +112.5% |
| FY2019 | $1.8M | +891.2% |
| FY2018 | $181.0K | -21.0% |
| FY2017 | $229.0K | -9.1% |
| FY2016 | $252.0K | -14.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026